Vincerx Pharma, Inc. (VINC) Misses Q1 EPS by 44c

Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q1 EPS of ($0.68), $0.44 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Genco rejects Diana Shipping bid, calls offer below NAV